45 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
with milestones to be established by the Board. Mr. Buckler was entitled to receive a retention bonus where the Company will pay $45,000 on the earlier … and enforce compliance with the Code;
(ll) establish procedures for: i) the receipt, retention and treatment of complaints regarding accounting
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
9 Aug 23
Statement of Executive Compensation
7:41pm
was entitled to receive a retention bonus where the Company will pay $45,000 on the earlier of April 30, 2016 or 30 days after the Company completed
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
by the Board. Mr. Buckler was entitled to receive a retention bonus where the Company will pay $45,000 on the earlier of April 30, 2016 or 30 days after
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
7 Jul 22
Statement of Executive Compensation
1:43pm
a retention bonus where the Company will pay $45,000 on the earlier of April 30, 2016 or 30 days after the Company completes an equity financing
6-K
EX-99.1
gjdqe wvmm
30 Jun 22
Statement of Executive Compensation
11:16am
6-K
EX-99.1
3gbrjnuqlrh2cdvv6vqn
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
20-F/A
7r5fuhae63aa18 brmq
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.3
5xdtjsjd
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
h6jf eqggzmtau
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.1
bik 0jdn3i
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
m8skr57wy faalrj
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
jgi fqkh1
22 Jan 19
Current report (foreign)
4:43pm